Effects of miR-203a targeting and its target gene on lymph node metastasis of breast cancer

doi:10.12047/j.cjap.6041.2020.126

Abstract

Abstract: Objective: To study the expression and correlation of mir-203a and its target gene ATM in breast cancer tissues, so as to provide theoretical basis for the pathogenesis of breast cancer, especially lymph node metastasis. Methods: Thirty paired breast cancer and paracancer normal tissues were collected, and RT-qPCR was used to detect the relative expression levels of mir-203a and ATM in the samples of the two groups. Correlation analysis was conducted for mir-203a and ATM, and correlation analysis was conducted for the pathological characteristics, so as to compare whether there were statistical differences between mir-203a and ATM in lymph node metastasis and non-metastasis. Results: Compared with normal paracancer tissues, the expression level of mir-203a in breast cancer tissues was significantly increased (P＜0.01), and the expression level of ATM was significantly decreased (P＜0.01), showing a significant negative correlation between the two tissues (r=-0.847,P＜0.01).The expression level of mir-203a and ATM was significantly correlated with lymph node metastasis and different clinical stages (P＜0.05). The expression level of mir-203a in the group with lymph node metastasis were significantly lower than that in the group without lymph node metastasis (P＜0.05), and the expression of ATM in the group with lymph node metastasis was significantly higher than that in the group without lymph node metastasis (P＜0.01). Conclusion: The overexpression of mir-203a in the early stage of breast cancer may inhibit the expression of its target gene ATM, which may be a protective mechanism to regulate the proliferation,metastasis and invasiveness of tumor cells. In the middle and late stage, mir-203a is down-regulated and the ATM gene is up-regulated, which may be involved in lymph node metastasis.

Key words: MiR-203a, ATM, target genes, breast cancer, lymph node metastasis

CLC Number:

HAN Li-rong, SONG Jiang-qin, GUO Fei-bo, ZHANG Dong-wu. Effects of miR-203a targeting and its target gene on lymph node metastasis of breast cancer[J]. CJAP, 2020, 36(6): 600-604.

References

[1] Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer[J]. Nat Rev Cancer, 2015, 15(6): 321-333.
[2] Zhou P, Jiang N, Zhang GX, et al. MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM[J]. Acta Biochim Biophys Sin (Shanghai), 2016, 48(8): 696-703.
[3] Yang CH, Wang Y, Sims M, et al. MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway[J]. Oncotarget, 2017, 8(68): 112980-112991.
[4] Wang L, Tong D, Guo Q, et al. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells[J]. Sci Rep, 2018, 8(1): 2431-2441.
[5] 吴晓斌, 许红英, 徐慧. miR-203a-3p通过靶向PRMT5抑制胃癌细胞增殖[J]. 现代肿瘤医学, 2017, 25(14): 2226-2230.
[6] Na XY, Shang XS, Zhao Y, et al. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4[J]. Neoplasma, 2019, 66(2): 211-221.
[7] Gomes BC, Martins M, Lopes P, et al. Prognostic value of microRNA-203a expression in breast cancer[J]. Oncol Rep, 2016, 36(3): 1748-1756.
[8] Jin MH, Oh DY. ATM in DNA repair in cancer[J]. Pharmacol Ther, 2019, 203: 107391.
[9] Bartkova J, Horejsí Z, Koed K, et al. Damage response as a candidate anti-cancer barrier in early human tumorigenesis[J]. Nature, 2005, 434(7035): 864-870.
[10] Hsia SM, Yu CC, Shih YH, et al. Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma[J]. Head Neck, 2016, 38(Suppl 1): E360-371.
[11] Choi M, Kipps T, Kurzrock R.ATM mutations in cancer: Therapeutic implications[J]. Mol Cancer Ther, 2016, 15(8): 1781-1791.
[12] 刘显荣, 卢先州. ATM基因与胰腺导管腺癌发病及放疗增敏研究进展[J].现代临床医学, 2018, 44(1): 5-8.
[13] Rondeau S, Vacher S, De Koning L, et al. ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels[J]. Br J Cancer, 2015, 112(6): 1059-1066.
[14] Liu HY, Zhang YY, Zhu BL, et al. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM[J]. J Ovarian Res, 2019, 12(1): 60-72.
[15] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15(7): e279-289.
[16] 乳腺癌诊疗规范(2011年版)[J].中国实用外科杂志, 2011, 31(10): 902-907.
[17] Cai KT, Feng CX, Zhao JC, et al. Upregulated miR 203a 3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta analysis[J]. Mol Med Rep, 2018,18(6): 4994-5008.
[18] Bueno RC, Canevari RA, Villacis RA, et al. ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas[J]. Ann Oncol, 2014, 25(1): 69-75.
[19] 郎磊. ATM对乳腺癌细胞迁移和侵袭影响及其机制研究[D]. 重庆: 重庆医科大学, 2017.
[20] Zhang Z, Zhang B, Li W, et al. Epigenetic silencing of miR-203 upregulates SNAI2 andcontributes to the invasiveness of malignant breast cancer cells[J]. Genes Cancer, 2011, 2(8): 782-791.
[21] Sun M, Guo X, Qian X, et al. Activation of the ATM-Snail pathway promotes breast cancer metastasis[J]. J Mol Cell Biol, 2012, 4(5): 304-315.